Raphael Teipel

Real-world analysis of teclistamab in 123 RRMM patients from Germany

Christine Riedhammer, Florian Bassermann, Britta Besemer et al. · Leukemia · 2024 · 104 citations · Full text

Medicine, Pathology, Molecular Pathology +2

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

Raphael Teipel, Frank Kroschinsky, Michael Krämer et al. · Blood Advances · 2022 · 56 citations · Full text

Life Sciences, Hematology, Immunology +15

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

Bruno Paiva, Irene Manrique, Meletios Α. Dimopoulos et al. · Blood · 2022 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · The Lancet Haematology · 2024 · 49 citations · Full text

Medicine, Hematology, Oncology +15

Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors

Raphael Teipel, Johannes Schetelig, Michael Krämer et al. · Transfusion · 2015 · 46 citations

Medicine, Biostatistics, Hematology +17